GOP turns up heat on mifepristone
Click in for more news from The Hill {beacon} Health Care The Big Story GOP turns up heat on mifepristone Pressure is mounting from the right on the Trump administration to restrict access to mifepristone, one of the drugs used in medication abortions. © AP Conservative lawmakers and anti-abortion groups said they felt betrayed […]
Ozempic under scrutiny: Are digestive disorders the untold side effect?
(NaturalNews) Patients on GLP?1 drugs like Ozempic, Wegovy and Mounjaro are increasingly reporting severe gastrointestinal symptomsânot merely mild nausea, bu…
Oct 10 2025 This Week in Cardiology
GLP-1 use in HFrEF, left atrial posterior wall isolation during AF ablation, peri-device leaks for LAAO, new findings in post-cardiac surgery AF, and imaging before AF ablation are the topics John Mandrola, MD, discusses in this week’s podcast. theheart.org on Medscape
GLP-1s are reshaping bodies and budgets
Michelle, a 42-year-old marketing executive, was scrolling through her grocery app when she saw the total: $87. A year ago, her weekly cart never dipped below $200. Chips, late-night snacks, and bottles of wine had given way to produce, yogurt, and lean proteins. But that same morning, a $900 charge for her GLP-1 prescription landed […]
NC Woman Faces 170 Felony Charges in Insurance Fraud Involving Stolen GLP-1 Drugs
A North Carolina woman has been busy over the last three years, illegally obtaining weight-loss medication, administering it to people, and defrauding insurance companies of more than $87,400, the state Department of Insurance alleged this week. Heather Ann Robinson, 37, …
Dr Megan Rossi and Gemma Ogston on how to heal your gut and eat 30 plants a week
Gut health is one of the biggest trends of the year. It’s a catch-all term that’s been used to sell supplements, spook people about their diets and encourage disordered eating. But it’s also prompted a spike in sales of gut-friendly foods, an uptick in body literacy and an arguably healthier population. Leading gut health expert […]
Large Number of GLP-1 Prescriptions Go Unfilled
(MedPage Today) — Nearly half of patients prescribed a GLP-1 receptor agonist were not filling the order, with certain factors playing a role, according to a cohort study. Among nearly 10,000 GLP-1 receptor agonist prescriptions given at a single…
Can Novo Nordisk’s Aggressive Deal-Making Offset Semaglutide Reliance?
Novo Nordisk NVO continues to derive the bulk of its revenue from its blockbuster semaglutide (GLP-1 RA) therapies, Wegovy for obesity and Ozempic for type II diabetes (T2D). Together, the drugs generated DKK 101.41 billion in the first half of 2025, representing about 65% of total sales. However, this heavy dependence has made the company […]
STAT+: AstraZeneca to make obesity drugs in new Virginia plant
Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox. Quick programming note: This newsletter will take a break for the Monday holiday, but we’ll be back in your inbox bright and early Tuesday. We’re lining up some great stories for next week, and […]
Exclusive-Bill Gates, PAHO Consider Ways to Bring Weight-loss Drugs to Lower-income Countries
The Gates Foundation and the Pan American Health Organization are both working on ways to make weight-loss drugs like Novo Nordisk’s Wegovy and Eli Lilly’s Mounjaro more… Reuters Health Information